JPS49126661A - - Google Patents
Info
- Publication number
- JPS49126661A JPS49126661A JP49028209A JP2820974A JPS49126661A JP S49126661 A JPS49126661 A JP S49126661A JP 49028209 A JP49028209 A JP 49028209A JP 2820974 A JP2820974 A JP 2820974A JP S49126661 A JPS49126661 A JP S49126661A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0029—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US344838A US3890356A (en) | 1973-03-26 | 1973-03-26 | 7-Alkyl-{66 {hu 3,5{b -steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS49126661A true JPS49126661A (xx) | 1974-12-04 |
Family
ID=23352273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49028209A Pending JPS49126661A (xx) | 1973-03-26 | 1974-03-13 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3890356A (xx) |
| JP (1) | JPS49126661A (xx) |
| AU (1) | AU6558474A (xx) |
| BE (1) | BE812836A (xx) |
| CA (1) | CA1027929A (xx) |
| DE (1) | DE2413559A1 (xx) |
| FR (1) | FR2223014A1 (xx) |
| GB (1) | GB1410294A (xx) |
| ZA (1) | ZA74932B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
| MX9301121A (es) | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
| US7704983B1 (en) | 1992-03-02 | 2010-04-27 | Eastern Virginia Medical School | Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception |
| US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| US5516769A (en) * | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
| US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
| DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3351639A (en) * | 1963-03-20 | 1967-11-07 | American Cyanamid Co | 17-alkyl-20-keto substituted pregnenes, pregnadienes and methods of preparing the same |
| US3246022A (en) * | 1964-06-04 | 1966-04-12 | Searle & Co | 3-aryl-17beta-oxy (androsta/estra)-3, 5-dienes |
| US3471531A (en) * | 1966-04-07 | 1969-10-07 | Herchel Smith | Synthesis of gona-3,5-dienes |
| CH537373A (de) * | 1966-10-28 | 1973-05-31 | Ciba Geigy Ag | Verfahren zur Herstellung neuer 7d-Methyl- 3,5--östradiene |
| US3553213A (en) * | 1969-03-17 | 1971-01-05 | American Home Prod | 17-alpha-aminoalkynyl-3-chloro 19-norsteroidal 3,5-dienes |
-
1973
- 1973-03-26 US US344838A patent/US3890356A/en not_active Expired - Lifetime
-
1974
- 1974-02-12 ZA ZA00740932A patent/ZA74932B/xx unknown
- 1974-02-14 AU AU65584/74A patent/AU6558474A/en not_active Expired
- 1974-02-15 CA CA192,667A patent/CA1027929A/en not_active Expired
- 1974-03-13 JP JP49028209A patent/JPS49126661A/ja active Pending
- 1974-03-20 GB GB1236874A patent/GB1410294A/en not_active Expired
- 1974-03-21 DE DE2413559A patent/DE2413559A1/de active Pending
- 1974-03-22 FR FR7409975A patent/FR2223014A1/fr not_active Withdrawn
- 1974-03-26 BE BE142453A patent/BE812836A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6558474A (en) | 1975-08-14 |
| US3890356A (en) | 1975-06-17 |
| GB1410294A (en) | 1975-10-15 |
| DE2413559A1 (de) | 1974-10-17 |
| ZA74932B (en) | 1975-01-29 |
| BE812836A (fr) | 1974-07-15 |
| CA1027929A (en) | 1978-03-14 |
| FR2223014A1 (xx) | 1974-10-25 |